Clorazepate Dipotassium 13107-0284
Product NDC
13107-0284- Manufacturer
- Aurolife Pharma Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIV
- Marketing Start
- September 23, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA071858
Active Ingredients
| Ingredient | Strength |
|---|---|
| Clorazepate Dipotassium | 15 mg/1 |
Drug Class
Benzodiazepine [EPC]Benzodiazepines [CS]
Packaging Options(1)
100 TABLET in 1 BOTTLE, PLASTIC (13107-284-01)